Company Overview and News
New Zealand shares fell, led by Pushpay Holdings after the mobile app payments developer posted its first dip in quarterly revenue, while blue-chip stocks a2 Milk Co, Fletcher Building and Fisher & Paykel Healthcare declined. Infratil gained on upbeat earnings guidance.
New Zealand shares gained, led by Vital Healthcare Property Trust and A2 Milk Co, as investors prepared for a potential selloff of Fletcher Building once it updates its losses within its construction division.
New Zealand shares fell, led by Trustpower and Kiwi Property Group, while Fletcher Building and a2 Milk gained.
New Zealand shares were mixed as Fisher & Paykel Healthcare fell on the stronger Kiwi dollar while property stocks rebounded from earlier selling.
New Zealand shares slipped in thin holiday trading as appetite declined for companies offering attractive dividend yields, such as regulated utilities Chorus and Genesis Energy and pay-TV operator Sky Network Television.
New Zealand shares traded quietly in a truncated final session before Christmas, rising in light volume.
New Zealand shares fell, led lower by A2 Milk even as Synlait Milk gained, while Kiwi Property Group and Goodman Property declined.
New Zealand shares edged up to a new record, led by stock market operator NZX and as investors changed their tune on a2 Milk Co late in the day. Air New Zealand fell on disappointing monthly metrics.
New Zealand shares edged lower in quiet trading as investors weighed up the mixed messages from Wall Street on Friday and NZX's trading platform suffered an outage late in the day. Synlait Milk declined ahead of an investor update this week.
Rio Tinto, after months of speculation, appointed Simon Thompson as its next chairman to succeed Jan Du Plessis. — Reuters picSYDNEY, Dec 4 — Australian shares were steady today, as gains in materials stocks on strong commodity prices were offset by declines in the financial sector.
Kiwi Property Group wants to raise as much as $125 million selling seven-year bonds to repay bank loans and for general business use, joining the growing number of firms chasing cheaper capital through the listed debt market.
A new tool which shows how aligned a company's management is with its shareholders has been released by AUT's Auckland Centre for Financial Research.
New Zealand shares rose, led by Kathmandu Holdings ahead of its annual meeting, while Metro Performance Glass gained on its first-half earnings.
A rise in rental income has lifted the half year profit for the country's biggest commercial property investor.
Kiwi Property Group lifted first-half profit 5 per cent as the country's biggest listed property investor's rental portfolio benefited from new tenants coming on stream, even as the value of its portfolio was flat.
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...
2018-04-12 - Asif
Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...
as of ET